Dossier
obesity treatments
Coverage of obesity treatments in the Nexus archive.
- Eli Lilly and Novo Nordisk raise profit outlook as weight-loss drug demand soars
Eli Lilly and Novo Nordisk raised their profit outlooks due to increased demand for weight-loss drugs. Investors are showing a dim view of Novo Nordisk's over-reliance on obesity treatments, causing diverging share prices between the two drugmakers.
- Scientists discover a protein switch that burns fat and blocks new fat cells
Scientists discovered a protein called 'Mitch' that, when disabled in human cells, enhances fat burning, increases energy use, and inhibits new fat cell formation. Mice lacking Mitch were observed to be leaner, more athletic, and resistant to obesity.